上皮性卵巢癌、输卵管癌和原发性腹膜癌：概述

Q3 Medicine

Obstetrics, Gynaecology and Reproductive Medicine Pub Date : 2024-01-01 DOI:10.1016/j.ogrm.2023.10.004

Jane Borley

{"title":"上皮性卵巢癌、输卵管癌和原发性腹膜癌：概述","authors":"Jane Borley","doi":"10.1016/j.ogrm.2023.10.004","DOIUrl":null,"url":null,"abstract":"<div>Ovarian, fallopian tube and primary peritoneal cancer has the poorest survival outcomes of all gynaecological malignancies. The majority of women present with advanced stage, high grade disease following a period of generalised abdominal symptoms. There is currently no effective screening programme. Diagnosis is based on imaging and histology. Stratification of adnexal masses into benign and malignant categories has helped ensure appropriate patients are referred to the gynaecology oncology team. The mainstay of treatment is surgery and chemotherapy, with removal of all residual disease being one of the most important prognostic factors. Recent advances in targeted therapies are also beginning to improve outcomes.</div>","PeriodicalId":53410,"journal":{"name":"Obstetrics, Gynaecology and Reproductive Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epithelial ovarian, fallopian tube and primary peritoneal cancer: an overview\",\"authors\":\"Jane Borley\",\"doi\":\"10.1016/j.ogrm.2023.10.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>Ovarian, fallopian tube and primary peritoneal cancer has the poorest survival outcomes of all gynaecological malignancies. The majority of women present with advanced stage, high grade disease following a period of generalised abdominal symptoms. There is currently no effective screening programme. Diagnosis is based on imaging and histology. Stratification of adnexal masses into benign and malignant categories has helped ensure appropriate patients are referred to the gynaecology oncology team. The mainstay of treatment is surgery and chemotherapy, with removal of all residual disease being one of the most important prognostic factors. Recent advances in targeted therapies are also beginning to improve outcomes.</div>\",\"PeriodicalId\":53410,\"journal\":{\"name\":\"Obstetrics, Gynaecology and Reproductive Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obstetrics, Gynaecology and Reproductive Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1751721423001720\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrics, Gynaecology and Reproductive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1751721423001720","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

在所有妇科恶性肿瘤中，卵巢癌、输卵管癌和原发性腹膜癌的生存率最低。大多数妇女在出现全身腹部症状一段时间后，就会出现晚期、高级别疾病。目前还没有有效的筛查计划。诊断依据是影像学和组织学。将附件肿块分为良性和恶性两类有助于确保将适当的患者转诊到妇科肿瘤团队。治疗的主要方法是手术和化疗，切除所有残留病灶是最重要的预后因素之一。靶向疗法的最新进展也开始改善治疗效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Epithelial ovarian, fallopian tube and primary peritoneal cancer: an overview

Ovarian, fallopian tube and primary peritoneal cancer has the poorest survival outcomes of all gynaecological malignancies. The majority of women present with advanced stage, high grade disease following a period of generalised abdominal symptoms. There is currently no effective screening programme. Diagnosis is based on imaging and histology. Stratification of adnexal masses into benign and malignant categories has helped ensure appropriate patients are referred to the gynaecology oncology team. The mainstay of treatment is surgery and chemotherapy, with removal of all residual disease being one of the most important prognostic factors. Recent advances in targeted therapies are also beginning to improve outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Obstetrics, Gynaecology and Reproductive Medicine Medicine-Obstetrics and Gynecology

CiteScore

0.90

自引率

0.00%

发文量

期刊介绍： Obstetrics, Gynaecology and Reproductive Medicine is an authoritative and comprehensive resource that provides all obstetricians, gynaecologists and specialists in reproductive medicine with up-to-date reviews on all aspects of obstetrics and gynaecology. Over a 3-year cycle of 36 issues, the emphasis of the journal is on the clear and concise presentation of information of direct clinical relevance to specialists in the field and candidates studying for MRCOG Part II. Each issue contains review articles on obstetric and gynaecological topics. The journal is invaluable for obstetricians, gynaecologists and reproductive medicine specialists, in their role as trainers of MRCOG candidates and in keeping up to date across the broad span of the subject area.